Deep Genomics Appoints Thong Q. Le as Chair of the BOD
Deep Genomics, the AI-first TechBio group pioneering a brand new path for genomic medicines with its AI basis mannequin platform, in the present day introduced the appointment of Thong Q. Le as chair of its Board of Directors.
“Since becoming a member of our Board in 2025, Thong has been a trusted advisor and a robust advocate for our imaginative and prescient,” mentioned Brendan Frey, Founder and Chief Innovation Officer of Deep Genomics. “He brings a recent power and deep expertise supporting the life sciences business to the function, making him exceptionally effectively positioned to steer our Board as Deep Genomics continues to advance AI-driven drug discovery.”
Mr. Le joined the Deep Genomics Board of Directors in 2025, bringing greater than 20 years of expertise investing in the life sciences sector. Throughout his profession, he has guided high-impact investments and supported deal-making efforts which have pushed significant well being outcomes. He additionally serves as funding director and managing associate of the Strategic Investment Fund (SIF) for the Gates Foundation, and chairman of Accelerator Life Science Partners (ALSP), a enterprise capital agency devoted to constructing next-generation life science corporations.
As Chair, Mr. Le will assist information Deep Genomics via its subsequent part of development as the firm advances its inside pipeline towards medical growth, expands strategic collaborations, and additional establishes its management at the intersection of AI, genomics, and drug discovery.
“I’m honored to tackle the function of Chair of the Board of Directors at such an thrilling time for Deep Genomics and the broader TechBio business,” mentioned Le. “Deep Genomics has constructed a singular platform and world-class workforce main at the intersection of AI and biology. I stay up for persevering with my work alongside the firm as it advances its mission to rework how medicines are found and developed.”
Mr. Le succeeds Chip Baird, who served as Chair of the Board for the previous three years. Mr. Baird will proceed to assist Deep Genomics as a non-executive director and can serve as Chair of the Audit Committee.
To be taught extra about Deep Genomics’ work and its groundbreaking affect in the realm of genomic R&D, go to www.deepgenomics.com. For these fascinated with becoming a member of this workforce of TechBio innovators, go to https://www.deepgenomics.com/careers/.
The submit Deep Genomics Appoints Thong Q. Le as Chair of the BOD first appeared on AI-Tech Park.
